Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Injections for Intractable Plantar Keratoma
NCT04777227Completed
- Sponsor
- Université du Québec à Trois-Rivières
- Start
- Jun 2015
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of lidocaine, sponsored by Université du Québec à Trois-Rivières. Primary endpoints: Change from baseline in pain (Visual Analogue Scale) at 12 months and Change from baseline in Foot-Function-Index-Revised at 12 months. Started Jun 2015; status: completed.
02
Drugs
lidocaine
Beyond the preview
Go deeper on NCT04777227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04777227.